Clinical Trial Update: Study Assessing Safety and Therapeutic Activity of AFFITOPE® PD01A and PD03A in Patients With Early MSA [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update evaluating the safety and potential therapeutic activity of AFFITOPE PD01A and PD03A in patients with early Multiple System Atroph…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple System Atrophy

Drugs mentioned

• AFFITOPE PD01A (PD01A)
• AFFITOPE PD03A (PD03A)

Snippet

Sponsor: Affiris AG | Conditions: Multiple System Atrophy, Neurodegenerative Diseases | Phase 1 | Status: COMPLETED